Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Status:
Not yet recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The proposed proof-of concept trial aims at determining the effectiveness of metronidazole in
decreasing the Fusobacterium nucleatum load in tissues and possibly on its detrimental
effects on tumor cells and tumor microenvironment.